LFTS.F Stock Overview

An investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. More details

LFTS.F fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	1/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (28.2x) is below the Medical Equipment industry average (38x)

Earnings are forecast to grow 20.55% per year

Risk Analysis

Shares are highly illiquid

Significant insider selling over the past 3 months

Large one-off items impacting financial results

My Notes

Capture your thoughts, links and company narrative

LifeTech Scientific Corporation Competitors

IRADIMED

NasdaqGM:IRMD

US$764.3m

InMode

NasdaqGS:INMD

US$1.5b

LeMaitre Vascular

NasdaqGM:LMAT

US$2.3b

CONMED

NYSE:CNMD

US$2.2b

Price History & Performance

Summary of share price highs, lows and changes for LifeTech Scientific
Historical stock prices
Current Share Price	HK$0.23
52 Week High	HK$0.23
52 Week Low	HK$0.19
Beta	0.73
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-64.08%

Recent updates

Shareholder Returns

	LFTS.F	US Medical Equipment	US Market
7D	0%	-0.1%	-0.9%
1Y	n/a	13.7%	22.6%

Return vs Industry: Insufficient data to determine how LFTS.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how LFTS.F performed against the US Market.

Price Volatility

Is LFTS.F's price volatile compared to industry and market?
LFTS.F volatility
LFTS.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.8%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.7%
10% least volatile stocks in US Market	3.2%

Stable Share Price: LFTS.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine LFTS.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	1,448	Yuehui Xie	www.lifetechmed.com

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers.

LifeTech Scientific Corporation Fundamentals Summary

How do LifeTech Scientific's earnings and revenue compare to its market cap?
LFTS.F fundamental statistics
Market cap	US$1.03b
Earnings (TTM)	US$36.49m
Revenue (TTM)	US$175.64m

28.2x

P/E Ratio

5.9x

P/S Ratio

Is LFTS.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LFTS.F income statement (TTM)
Revenue	CN¥1.27b
Cost of Revenue	CN¥271.54m
Gross Profit	CN¥995.64m
Other Expenses	CN¥732.40m
Earnings	CN¥263.24m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.057
Gross Margin	78.57%
Net Profit Margin	20.77%
Debt/Equity Ratio	0%

How did LFTS.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/07 19:58
End of Day Share Price	2024/02/08 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LifeTech Scientific Corporation is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yuan Gao	China International Capital Corporation Limited
Hanqing Zhu	Guosen Securities Co., Ltd.
Yidong Zhang	Industrial Securities Co. Ltd.